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a  b  s  t  r  a  c  t
Ethylenethiourea  (ETU)  is of major  toxicological  concern,  since  in experimental  animal  studies,  ETU  has
shown  a  large  spectrum  of adverse  effects.  High  occupational  exposure  can  be  found  among  agricultural
workers  or  during  manufacturing  of  ethylenbisdithiocarbamates  (EBDC).  For the general  public,  sources
of environmental  exposure  may  be residues  of ETU in  commercial  products,  food  and  beverages.  For
the  determination  of ETU  in human  urine  we  present  a high-throughput  online  on-column  extraction
liquid  chromatography  triple  quadrupole  mass  spectrometry  method  using  direct  injection  of  hydrolysed
urine  samples.  This  method  is  simple,  user-  and  environmentally  friendly  and  all  sample  preparation  is
performed  in  96-well  plates.  A labelled  ETU internal  standard  was  used  for quantiﬁcation.  The  method
showed  a good  sensitivity  with a  limit  of quantiﬁcation  (LOQ)  of 0.5  ng ETU/mL  urine  and  the calibration
curve  was  linear  in  the  range  0.25–200  ng ETU/mL  urine.  The  within-run,  between-run  and  between-
batch  precision  was  between  6% and  13%.  Alkaline  hydrolysis  considerably  increased  the  levels of ETU
indicating  a potential  conjugate.  The  method  was  applied  in  an  experimental  dermal  exposure  study  in
humans,  with  sample  concentrations  ranging  from  0.4  to  5.0  ng  ETU/mL  urine.  The  excretion  in  urine
was  10%  of  the  applied  dose.  The  elimination  proﬁle  seemed  to differ  between  the  two  individuals.  The
results  show  an estimated  half-life  of ETU between  34  and  72  h. Although  the  experiment  is  limited  to
two  individuals,  the  data provide  valuable  and  new  information  regarding  the  toxicokinetics  of ETU  after
dermal  exposure.. Introduction
Ethylenbisdithiocarbamates (EBDCs) is a group of fungicides
f which ethylenethiourea (ETU) is an environmental degradation
roduct as well as a metabolite and impurity. Potential sources of
TU exposure to humans may  be occupational or environmental.
ccupational exposure may  be high among agricultural workers
nd among workers manufacturing EBDCs [1–9]. Further, ETU is
sed as a vulcanization agent in the production of polychloro-
rene (neoprene) and polyacrylate rubbers and in several other
roducts such as dyes. In the general population, residues of ETU
Abbreviations: ADI, acceptable daily intake; b.w., body weight; CID, collision
nduced dissociation; EBDC, ethylenbisdithiocarbamates; ETU, ethylenethiourea; IS,
nternal standard; LC/MS/MS, liquid chromatography triple quadrupole mass spec-
rometry; LOD, limit of detection; LOQ, limit of quantiﬁcation; QC, quality control.
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in products can be one of many sources of environmental expo-
sure to ETU. Associations have been observed between ETU, and
smoking, wine drinking and consumption of fruit and vegetables
[4,10]. ETU is of major toxicological concern. In animal studies, ETU
has caused a large spectrum of adverse effects, mainly concern-
ing mutagenic, teratogenic, carcinogenic and hepatogenic effects
[11–13]. However, the evidence for such effects in humans is less
well founded. ETU has been classiﬁed to be “reasonably anticipated
to be a human carcinogen” based on sufﬁcient evidence of car-
cinogenicity from animal experiments [14]. Some data suggest that
ETU affects the lymphocyte genome and the thyroid gland among
heavily exposed workers [1,2,15]. Both for EBDCs and ETU, there
is a need for large scale epidemiological studies of exposure-effect
relationships. In such studies, an accurate exposure assessment is
required. Biomarkers have many advantages in comparison with
other methods of exposure assessment, but reliable analytical
methods are needed. Many analytical methods for measurement of
Open access under CC BY license.ETU in biological samples have been presented [16]. Several mass
spectrometry (MS) based analytical methods for quantiﬁcation of
the low levels of ETU present in human urine after occupational
or environmental exposures, using gas chromatography/mass
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pectrometry (GC/MS) [17], and liquid chromatography/tandem
ass spectrometry (LC/MS/MS) have been developed [18–21].
owever, these methods are all laborious, time-consuming and not
uitable for epidemiological studies.
Dermal exposure is thought to play an important role in the
isk assessment of pesticides [22]. However, the knowledge of der-
al  exposure to pesticides is limited. Moreover, there is only little
nowledge of exposure assessment techniques for quantiﬁcation
f dermal exposure. For data of biomarker levels to be useful, sup-
orting toxicokinetic data are needed. Knowledge of the parent
ompound and the major metabolites excreted in urine, including
he excretion half-life, is important [23]. In guinea pigs, dermally
xposed to ETU, 14% of the applied dose was absorbed after 24 h
24]. There are several occupational studies addressing dermal
BDC and ETU exposure. Dermal exposure to ETU is related to
he presence of ETU as contaminant in EBDC-based formulation,
r in re-entry workers that come in contact with treated crops
here EBDC degradation products may  be present. In studies of
gricultural workers exposed to EBDC, dermal exposure to ETU
as measured using ﬁlter pads [8,25]. A signiﬁcant correlation was
ound between end-shift ETU levels in urine and the measured lev-
ls on pads [25]. This result is in agreement with a study of workers
t a production plant where ETU levels in urine correlated with
BDC contamination on the hands [5]. Earlier, no studies of exper-
mental dermal exposure to ETU have been performed in humans.
n the other hand very few pesticide dermal exposure studies have
een performed in humans [22,26–29].
The aim of this study was to develop a high-throughput online
n-column extraction LC/MS/MS method for analysis of ETU in
uman urine. The method was applied in a human experimental
ermal exposure study of ETU.
. Materials and methods
.1. Chemicals and materials
The internal standard (IS) [2H4]-ETU was purchased from Dr.
hrenstorfer (Augsburg, Germany). Hexane was from Lab-Scan
Dublin, Ireland). Sodium hydroxide (NaOH), hydrochloric acid
HCl) and methanol (hyper grade for LC–MS) were from Merck
Darmstadt, Germany). ETU was a PESTANAL® analytical standard,
ormic acid (FA), pentaﬂuorobencyl bromide (PFBr) and tetrabutyl-
mmonium hydrogen sulphate (TBA) were from Sigma–Aldrich Inc.
St. Louis, MO,  USA). Puriﬁed water from a Millie-Q Integral 5 sys-
em (Millipore, Billerica, MA,  USA) was used.
Plastic 96-well-plates SQW block with clear glass insert vials
.5 mL,  SQW 45 × 7.7 mm,  sealed with a welled sealmat block cover,
as from La-Pha-Pack®GmbH (Langerwehe, Germany) and 96-
ell-aluminium plates with1.5 mL  aluminium block cover, was
rom J.G. Finneran Associates, Ltd (Surrey, United Kingdom).
.2. Instrumentation
Quantitative analysis was conducted using a triple quadrupole
inear ion trap mass spectrometer, equipped with TurboIonSpray
ource (QTRAP 5500; AB Sciex, Foster City, CA, USA) coupled to a liq-
id chromatography system with four pumps (UFLCRX, Shimadzu
orporation, Kyoto, Japan). The MS/MS  analyses were carried out
sing selected reaction monitoring (SRM) in positive atmospheric
ressure chemical ionization (APCI) mode. Air was used as neb-
lizer spraying gas. Pure nitrogen was used as curtain gas and
ollision gas. The APCI temperature was set at 450 ◦C. The instru-
ent was tuned to a peak resolution of 0.5 ± 0.1 Da at half the peak
eight in high resolution mode. To establish the appropriate SRM
onditions, standard solutions were infused into the MS/MS  forgr. B 934 (2013) 53– 59
optimization. Collision-induced dissociation (CID) of each [M+H]+
was performed and the product ions giving the best signal to noise
ratio were selected for the SRM analysis. All data acquisition and
processing was  performed using the Analyst 1.5.1 application soft-
ware (Applied Biosystems, Foster City, CA, USA).
2.3. Preparation of calibration standards, quality control and
samples
Stock solutions were prepared in duplicates by dissolving accu-
rately weighed amounts of [2H4] ETU (IS) and ETU in methanol.
The IS and ETU standard stock solutions were diluted further in
methanol and stored at −20 ◦C. Urine samples for the calibration
standards and for quality control samples were obtained from
healthy volunteers at our laboratory.
For the calibration curve, 475 L blank urine was spiked with
25 L of the standard solutions and 25 L of the IS solution, giving
a urinary concentration between 0.25 and 200 ng ETU/mL and 5 ng
[2H4] ETU/mL urine. The calibration curve was corrected with the
amount found in the urine. As quality control (QC) urine samples
naturally containing 2 and 7 ng ETU/mL and the 7 ng/mL QC spiked
to 32 ng/mL were used. The low, medium and high QC-samples
were divided into several aliquots and stored at −20 ◦C. The chem-
ical blank was prepared from Millie-Q water and thereafter treated
like the other samples. The urine samples and QC-samples were
vortex-mixed after thawing and aliquots of 500 L were transferred
into 1.5 mL  glass vials and placed in an aluminium 96-well plate,
and 25 L of IS solution was added.
For the hydrolysis, 20 L of 2.5 M NaOH was  added to the sam-
ples, standards, QC-samples and chemical blanks, giving a ﬁnal
concentration of 0.09 M NaOH. To prevent evaporation during
hydrolysis the glass-vials were sealed with a sealmat and a cover
was screwed on. After sealing, the samples were mixed thoroughly
for 1 min  and then transferred to a heating oven. Hydrolysis was
performed for 1 h at 100 ◦C. The aluminium 96-well-plates was
used in the hydrolysis step, because of the possibility to secure the
cover of the vials with four screws and the capacity of fast temper-
ature transfer throughout the plate. After hydrolysis, the samples
were cooled to room temperature and the glass vials were moved to
plastic 96-well-plates compatible with the autosampler. Aliquots
of 15 L of 5 M HCl were added to acidify the samples. The sam-
ples were mixed thoroughly and centrifuged for 10 min  at 2600 × g
before analysis.
2.4. Analysis
The two mobile phases used consisted of 0.1% (v/v) FA in water
(mobile phase A) and 0.1% (v/v) FA in methanol (mobile phase B).
The two  dimensional separation was  carried out, using two iden-
tical analytical columns Genesis® Lightn AQ (C18, 4.6 × 100 mm,
4 m,  Grace Vydac, Hesperia, CA, USA) and two sets of LC pumps,
each set containing two  pumps. The columns and LC pumps were
connected through a diverter valve. An aliquot of 20 L of the sam-
ple was injected on the ﬁrst column and the separation was  carried
out by isocratic elution, using 100% mobile phase A and a ﬂow rate
of 0.7 mL/min. After 2.5 min, the diverter valve switched over and
the efﬂuent was  diverted into the second column during 1 min  and
thereafter the diverter valve switched over again. The second set of
pumps continued the isocratic elution of the analytes on the sec-
ond column, using 100% mobile phase A. A diverter valve on the
MS diverted the column efﬂuent to the MS  between 4.6–6.9 min.
The ﬁrst column was  cleaned with 95% mobile phase B at a ﬂow
rate of 1.2 mL/min for 1 min, followed by equilibration with 100%
mobile phase A for 2.5 min, during the time ETU was eluting on the
second column. The second column was  reconditioned with 95%
mobile phase B for 0.5 min  in the end of the analytical run and then
E. Ekman et al. / J. Chromato
Table 1
Summary of the SRM transitions for ETU and [2H4] ETU used in the LC/MS/MS
analysis.
Compound Transitions (Da) Collision energy (V)
Quantiﬁer ions
ETU 103.1 → 60.0 42
[2H4]ETU 107.1 → 48.0 25
Qualiﬁer ions
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[2H4]ETU 107.1 → 64.0 42
quilibrated with 100% mobile phase A for 2.5 min  in the beginning
f the next analytical run. The columns were maintained at 40 ◦C.
he LC/MS/MS analysis was performed using SRM transitions and
ollision energies for ETU and IS quantiﬁer ion and qualiﬁer ions
s tabulated in Table 1. All samples were prepared in duplicates
nd analyzed by single injections. Concentrations were determined
y peak area ratios between analyte and the IS. All values were
orrected for the chemical blank.
.5. Sample preparation for cross method comparisons
Sample preparation and analysis were performed according to
 previously described method using an extractive derivatisation
18]. In this method, there was an incomplete hydrolysis, thus we
ncluded hydrolysis at 0.09 M and 100 ◦C as a minor modiﬁcation.
he samples were prepared in 13 mL  glass tubes. Samples and cali-
ration standards were prepared as in Section 2.3. The sample was
ydrolysed for 1 h at 100 ◦C after an addition of 20 L of 2.5 M NaOH.
fter cooling, the derivatisation reagents 0.4 M TBA, 10 M NaOH,
ichloromethane and PFBr were added. The samples were deriva-
ised for 90 min  in an ultrasonic bath and analyzed by LC/MS/MS.
.6. The impact of hydrolysis
Determination of the optimal time for hydrolysis was  performed
sing an authentic urine sample, previously quantiﬁed to contain
 ng ETU/mL urine. Samples were prepared in triplicates for nine
ime points between 0 and 240 min. The test was performed at
 constant amount of 0.09 M NaOH and a temperature of 100 ◦C,
xcept for the non-hydrolysed sample.
To test the impact of hydrolysis on real samples, ten urine sam-
les were selected from an experimental oral exposure to an EBDC
mancozeb) [18]. Five samples were from a male volunteer (A) and
ve samples from a female volunteer (B). All samples were prepared
n duplicates and prepared with and without hydrolysis according
o the presented method. In the samples without hydrolysis, NaOH
nd HCl were mixed just before addition to the samples to avoid
ydrolysis.
.7. Validation of the analytical method
Limit of detection (LOD) and limit of quantiﬁcation (LOQ) were
etermined as the mean level of the peak, within 0.1 min  of the
xpected retention time of ETU, plus three and ten times the
tandard deviation, respectively [30]. LOD and LOQ were deter-
ined in chemical blank samples (n = 14). To assess the LOD and
OQ in urine matrix, 11 samples with known low ETU levels were
elected and then analyzed.
The linear range of the calibration curve was determined from
en concentration levels between 0.25 and 200 ng ETU/mL urine.
he equation of the curve was calculated by linear regression and
he correlation coefﬁcient (r) was used as a measure of the ﬁt of the
urve.
The precision of the method was determined using three dif-
erent approaches, within-run, between-run and between-batchgr. B 934 (2013) 53– 59 55
precision. The precision was  calculated as the coefﬁcient of varia-
tion (CV) of repeated measurements. The within-run precision was
obtained from spiked urine at three concentration levels, 1, 10 and
100 ng ETU/mL urine. The samples were divided into ten aliquots
and the sample preparation was performed in one sample batch,
during one day.
The between-run precision was determined by including the
three QC urine samples, containing 2, 7 and 32 ng/mL of ETU, in
eleven analytical sample batches. The QC-samples were prepared
in duplicates in each different analytical sample batch. The batches
were prepared and analyzed on separate days, during a period of
six months. Thus, the standard deviation was calculated from 11
individual mean results.
A between-batch precision of the method was determined by
analysis of 88 urine samples collected in the dermal exposure study
(see below). Each urine sample was divided into two aliquots which
were then subjected to the entire analytical procedure. The samples
were prepared and analyzed in separate analytical batches and on
different days. The CV was  calculated as previously described [18].
The mean obtained concentration was  measured at three con-
centration levels for the spiked samples used to determine the
within-run precision method.
The stability of the ETU standard solutions in methanol was
investigated by reanalysis after storage in −20 ◦C for 7 months.
A cross-method comparison was conducted. The ten urine sam-
ples described in Section 2.6 were prepared using the method in
Section 2.5 and compared with the here presented method. The
results were compared using linear regression.
2.8. Human experimental study of dermal exposure
Two  healthy volunteers, one male (age 42; weight 75 kg) and
one female (age 65; weight 56 kg) participated in the study. They
had given their written informed consent and the study was ethi-
cally approved by The Regional Ethical Review Board in Lund, Lund
University, Sweden (721-1395-05 mM and Dnr2013/6). The partic-
ipants minimized the intake of conventionally grown food a few
days before as well as during the study. The two subjects received
one single dose, administrated topically on the inner forearm on
an area of 75 cm2. The dose to the male volunteer consisted of an
accurately weighed amount of ETU, dissolved to a concentration
of 3 mg/mL  of ethanol/water 50% (v/v), giving 0.30 mg in 100 L.
The female received an aliquot, diluted with ethanol/water 50%
(v/v) to a ﬁnal concentration of 0.22 mg  in 100 L. The doses corre-
sponded to the accepted daily intake (ADI) for ETU, 4 g/kg b.w./day
[31] assuming 100% absorbtion. After administration, the vehicle
was allowed to evaporate to dryness before the skin was  covered
with aluminium foil. After 8 h of exposure, the cover was  removed.
The remainder of the dose was  wiped off the exposed area four
times using ethanol/water 50% (v/v) and cotton swabs. Thereafter,
the subjects cleaned their forearms with soap and water. The alu-
minium foil and cotton swabs were stored at −20 ◦C until analysis.
Before analysis, ETU on the aluminium foil and cotton swabs was
recovered by extraction into 1 L of Millie-Q water.
The ﬁrst urine sample was collected immediately prior to the
exposure and then in intervals ad libitum during 144 h for the male
subject and 170 h for the female. All urine voided was  collected.
All samples were stored at −20 ◦C until analysis. Sample volume,
creatinine and density were determined in all the collected sam-
ples to adjust for the urinary dilution. Creatinine was analyzed with
an enzymatic method [32] and density with a hand refractometer.
The concentration adjusted for urinary density, Cd, was  calculated
according to the equation Cd = C(observed) × (1.016 − 1)/( − 1),
where C(observed) is the obtained concentration in the urine sam-
ple,  is the measured speciﬁc density and 1.016 was used as the
average urine density [33]. The half-life (t½) of the elimination in
56 E. Ekman et al. / J. Chromatogr. B 934 (2013) 53– 59
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Fig. 1. LC/MS/MS SRM chromatogram showing a urine sample naturally contain-
ing ETU and quantiﬁed to a concentration of 7 ng/mL, for the quantiﬁer transition
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Table 2
Increase in ETU levels after hydrolysis in ten urine samples, ﬁve samples collected
from two individuals [27].
Sample Subject Non hydrolysed
ETU concentration
(ng/mL)
Hydrolysed ETU
concentration
(ng/mL)
1 A 2.4 9.7
2  A 3.8 18
3  A 4.0 21
4  A 0.4 7.7
5  A 0.2 1.2
6  B 0.2 2.7
7  B 2.3 16
8  B 1.9 13
urine showed excellent linearity with r = 0.999 and a slope of
0.0248 ± 0.0016 (n = 6).03.1–60.0 Da.
rine was estimated from the slope of the curve in the natural
ogarithm-linear (ln-linear) concentration versus time plot, where
ime is given as the mid  time points between two sample collection
ime points.
. Results and discussion
.1. Mass spectrometry and chromatography
Previously, published methods for the analysis of ETU in biologi-
al samples are too time-consuming for large scale epidemiological
tudies. We  here present a high-throughput method for the analysis
f ETU with direct injection of hydrolysed urine using 2 dimension-
C set up as an online on-column extraction. This method is simple
nd all sample preparation is performed in 96-well plates. Thus,
he method is environmental friendly with a signiﬁcant reduction
n solvent consumption. Also, we omitted dichloromethane com-
only used for sample preparation [9,17–21,34].
The chosen column provided consistent and reproducible chro-
atography and retained ETU with stable retention times even in
00% aqueous eluent. The direct injection of urine was possible
ince an online on-column extraction LC separation and two  sep-
rate switching valves were used. Thus, most of the urine matrix
as discarded, which reduced the chemical background and kept
he ion source clean. The cycle time for an analytical run, including
quilibration time, was 7.0 min. Thousands of injections were per-
ormed on the analytical columns before signs of degradation were
bserved.
ETU showed an excellent sensitivity in APCI and positive ion
ode. The transition 103.1/60 was chosen as the quantiﬁer ion,
ince it gave the best signal to noise ratio. A second SRM was  cho-
en as a qualiﬁer ion and used to strengthen the identity of the
nalyzed ETU in urine (Supplementary data Figs. S1a and S1b). The
ransitions and optimum collision energies are shown in Table 1.
hen the analysis was performed with the instrument in high res-
lution mode, a better signal to noise and a reduction of interfering
eaks was obtained. A typical chromatogram of a urine sample is
hown in Fig. 1 (Supplementary data Fig. S1c).9  B 2.9 12
10  B 1.9 3.5
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.jchromb.2013.06.035.
3.2. Hydrolysis
To evaluate the effect of hydrolysis, a urine sample was  treated
with 0.09 M NaOH at 9 different time point during 240 min. The
level in the non-hydrolysed urine was 0.1 ng ETU/mL. The lev-
els increased rapidly, and the highest ETU levels were found after
45 min. However, we chose 60 min  hydrolysis time in the method
(Supplementary data Fig. S2).
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.jchromb.2013.06.035.
To further evaluate the effect of hydrolysis, ten urine samples
from an earlier oral experimental exposure of two subjects was
analyzed with and without hydrolysis [18]. It was found that the
levels of ETU increased considerably in all samples after hydroly-
sis. The levels are shown in Table 2. The levels of hydrolysis and
non-hydrolysed urine samples were also compared using linear
regression. The curve shows a linearity with r = 0.88 and a slope
of y = 4.7x. Previously published methods for urine analysis have
not addressed hydrolysis or conjugation of ETU. Interestingly, it has
been shown that ETU can form protein adducts that can be released
with mild acid hydrolysis [35,36].
3.3. Validation of the analytical method
The LOD and LOQ for ETU determined from analysis of 14 chemi-
cal blanks were 0.08 ng/mL and 0.16 ng/mL respectively. Since there
seems to be a ubiquitous exposure to ETU, it is difﬁcult to obtain
urine samples with low ETU levels and this has an inﬂuence on the
value of the LOD. After selecting 11 urine samples with low levels
of ETU, the LOD was 0.2 ng/mL and the LOQ 0.5 ng/mL (Supplemen-
tary data Figs. S3a–S3c). The LOD was  in the same range as reported
in previous methods [9,17–21,34] and sufﬁcient for the measure-
ment of environmental human exposure. The CV was 19% in urine
samples spiked with 0.25 ng/mL (n = 6) and 10% at LOQ, 0.5 ng/mL
urine.
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.jchromb.2013.06.035.
For the calibration curves, urine with a low amount of ETU
were selected and then corrected with the amount found in the
urine. The obtained calibration curves in the range 0.25–200 ng/mLThe within-run, between-run and between-batch precisions are
presented in Table 3. The between-run precision was determined
E. Ekman et al. / J. Chromatogr. B 934 (2013) 53– 59 57
Table 3
Precision of the method at different concentration levels. The within-run precision
was  calculated from spiked urine samples and the between-run and batch precision
from authentic urine samples.
Precision ETU concentration
(ng/mL)
n  Mean obtained ETU
concentration
(ng/mL)
CV (%)
Within-run 1 10 1.2 9.9
10 10 11 13
100 10 98 12
Between-run 2 11 1.9 6.2
7  11 6.5 4.0
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Fig. 3. (a) Urinary absorption and elimination for the male volunteer with the mid-
point time in the interval 0–143 h was plotted against the density adjusted urinary
levels (ng/mL). The volunteer was  dermally exposed to a dose of 4 g/kg b.w. on
the inner forearm for 8 h. The ﬁrst two urine samples were collected just before and
1  h after administration of the dose. (b) Urinary absorption and elimination for the
female volunteer with the midpoint time in the interval 0–169 h was  plotted against32 11 28 6.1
Between batch Range 0.3–5.0 88 1.7 6.2
ver a period of six months. In Table 3, the obtained concentrations
t three concentration levels for spiked samples are presented.
The stability of the standard solutions of ETU dissolved in
ethanol was  examined and found to be stable for 7 months at
20 ◦C. Several studies have found that ETU is stable in urine sam-
les: in room temperature and in darkness for 24 h, at −20 ◦C for 6
onths [17], at 8 ◦C for 2 weeks, at −20 ◦C for 3 months [18], and
t −18 ◦C for 12 months [4].
A cross-method comparison was conducted using ten urine
amples from an oral experimental exposure of two  subjects and
nalyzed after hydrolysis using the here presented method and
 method using an extractive derivatisation and analysis using
C/MS/MS [18]. The obtained results showed an excellent correla-
ion when the levels were compared using linear regression giving
 linearity with r = 0.975 and the slope 1.00 (Fig. 2).
.4. Human experimental study of dermal exposure to ETU
In urine sampled before the experimental exposure, the ETU lev-
ls were for the female subject 0.8 ng/mL and for the male subject
.7 ng/mL, density adjusted. After the dermal exposure of ETU, cor-
esponding to a dose of 4 g/kg of b.w., the urinary levels increased
lowly. After about 24 h, a plateau was reached which lasted for
bout 50 h for the female and 30 h for the male subject Fig. 3a
nd for the female subject, Fig. 3b. Similar plateaus have also been
bserved in human dermal exposure studies of other pesticides
27–29,37]. The maximum ETU level was reached after 39 h and was
-1
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ig. 2. Ten hydrolysed urine samples analyzed with two different analytical meth-
ds in the cross-method comparison. Urinary levels of ETU obtained by the modiﬁed
ethod described by Lindh et al. [18] were plotted versus levels of ETU obtained by
he method reported in this paper. The equation of the straight line was obtained
y  linear regression and found to be y = 1.00x + 0.20 (r = 0.975).the density adjusted urinary levels (ng/mL). The volunteer was  dermally exposed to
a  dose of 4 g/kg b.w. on the inner forearm for 8 h. The ﬁrst two urine sample was
collected just before and 1 h after administration of the dose.
3.0 ng/mL (density adjusted) in the female subject and 5.0 ng/mL
(density adjusted) after 36 h in the male. The decline in elimination
of ETU was estimated to begin at 39 h in the female and at 36 h in
the male. For the calculation of the half-life of elimination, values
after 143 h for the female and 101 h for the male were discarded
due to low levels and a suspected interfering environmental expo-
sure. The half-lives of ETU with correlation coefﬁcients are shown
in Table 4. The urinary elimination of ETU for the male volunteer
is shown in Fig. 4a and for the female volunteer in Fig. 4b. Ear-
lier, attempts have been made to estimate elimination half-lives in
urine after occupational dermal and inhalation exposure to EBDC.
The half-lives vary considerably between the studies and are in the
Table 4
Estimated half-life of ETU found in the two volunteers, dermally exposed to a dose
of  4 g/kg b.w. of ETU for 8 h on an area of 75 cm2.
ETU urinary levels
adjusted for
Female t½a (h) rb Male t½a (h) rb
Density 72 0.89 34 0.94
Creatinine 75 0.75 29 0.89
Unadjusted 103 0.42 64 0.71
a The half-life of elimination (t½) in urine estimated from the slope of the curve
in  the natural logarithm-linear (ln-linear) concentration versus mid  time plot.
b Correlation coefﬁcient (r) for the regression line.
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Fig. 4. (a) Urinary elimination of ETU for the male volunteer, after dermal exposure
to  a dose of 4 g/kg b.w. of ETU for 8 h on an area of 75 cm2 on the inner forearm. The
half-life of elimination (t½) in urine is estimated from the slope of the curve in the
log-linear concentration versus time plot. Urinary elimination with the midpoint
time in the interval 36–101 h was  plotted against logarithm of the density adjusted
urinary levels (ng/mL). (b) Urinary elimination of ETU for the female volunteer, after
dermal exposure to a dose of 4 g/kg b.w. of ETU for 8 h on an area of 75 cm2 on the
inner forearm. The half-life of elimination (t½) in urine is estimated from the slope
of  the curve in the log-linear concentration versus time plot. Urinary elimination
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method has a sufﬁciently low LOD to enable detection of ETU inith the midpoint time in the interval 39–143 h was plotted against logarithm of
he  density adjusted urinary levels (ng/mL).
ange 32–100 h [7,8]. The half-life after an experimental oral expo-
ure to EBDC contaminated with ETU was estimated to 19–23 h for
ne female and one male [18]. Our study also contains only two
ndividuals of each sex, thus one should be careful to draw to many
onclusions. The half-life reported here differed more between the
ale and female volunteer compared to that of the oral exposure.
his may  indicate that the differences between sex and age have
arger impact on dermal absorption than on oral absorption. The
onger plateau for the female subject may  possibly be explained by
he fact that skin properties change with age and differ between
ndividuals and that may  have an impact on the dermal absorp-
ion. This is not surprising, since it is well known that, xenobiotic
etabolism and excretion kinetics varies greatly depending on age,
ex and activity level [22].
Of the administrated dermal dose, 35% was recovered from the
kin washings from the female and 24% from the male at the end
f the 8 h exposure. After deduction of the amounts in the wash-
ngs, the total recovery of ETU in the female urine was  10% of the
ose after 143 h. Correspondingly, in the male, 10% of the dose was
ecovered after 101 h. The results indicate a high uptake of ETU aftergr. B 934 (2013) 53– 59
dermal exposure. After an oral exposure of EBDC contaminated
with ETU, the recovery was  69–82% of the dose. [18].
The toxicokinetic data in this study indicate that an adjustment
for the urinary dilution is recommended and both creatinine lev-
els and urinary density may  be applied. Density gave the best ﬁt
of the adjusted values. Most often, though, creatinine levels have
been used to adjust for urinary dilution. However, creatinine levels
may be affected by several factors such as gender, age, muscular-
ity, and consumption of meat. Also urinary density may  be affected
by similar factors, but a recent study has shown that urinary cad-
mium levels adjusted for creatinine was more affected by gender,
age, body size and meat intake than adjustment using urinary den-
sity [38]. When comparing individuals or populations with large
differences in muscle mass, meat intake, or when both males and
females of various ages are included, density adjustment may  be
the more applicable.
In our study, 0.1 mL  of ethanol/water 50% (v/v) solution was cho-
sen to get an even dispersal of ETU over the application area. The
solution evaporated within a minute before the skin was  occluded
to protect the surface. We  therefore assume that the use of an
ethanol solution had minimal effect on the permeation of ETU. The
use of ethanol as vehicle and washing solution has been used in
other dermal absorption studies [27,28]. Occlusion of the exposed
skin may  also affect the dermal absorption by enhancing the hydra-
tion and temperature of the skin. Further, washing of the exposed
skin may  enhance the dermal absorption, especially if using soap.
Surfactants have shown to alter the properties of the skin barrier
[22].
We  chose to expose the forearm of the subjects, the most com-
monly used anatomic site in dermal experimental exposure studies
[22,26–29]. However, it has been shown that the forearm is less per-
meable compared to the forehead and the neck. This difference is
due to skin thickness and amount of appendage like hair follicles,
sweat- and sebaceous glands. Thus, the absorption may  be higher,
if other more permeable areas of the body are exposed [5,8].
3.5. Application of high-through put method in an
epidemiological study
Spot urine samples (n = 1282) were collected from individuals
environmentally exposed to EBDCs and ETU. Data from this study
will be published elsewhere. All samples were divided into two
aliquots and analyzed in duplicate sample batches. A total of
32 96-well plates were prepared with six QC samples per plate.
Sample concentrations ranged from 0.3 to 210 ng ETU/mL. The
between-run precision determined from QC samples were CV = 19%
at 2.3 ng/mL (n = 63), CV = 11% at 7.1 ng/mL (n = 62) and CV = 9.3% at
30 ng/mL (n = 63). The samples were prepared and analyzed during
about 2 months. Thus, the method is applicable in large epidemi-
ology studies.
4. Conclusions
We  present a high-throughput method for the analysis of ETU
with direct injection of hydrolysed urine using online on-column
extraction LC/MS/MS. This method is simple and user-friendly and
all sample preparation is performed in 96-well plates. The method
is environmentally friendly with a signiﬁcant reduction in solvent
consumption. The urinary levels of ETU increased considerably
after alkaline hydrolysis at 0.09 M NaOH. The method has excel-
lent within-run, between-run and between-batch precisions. Theenvironmentally exposed populations.
The method was applied in a human experimental dermal
exposure study where about 10% of the applied dose of ETU
mato
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as recovered in urine. The elimination proﬁle seemed to dif-
er between the two subjects. Although this study is limited to
wo individuals, the data provide valuable and new information
egarding the toxicokinetics of ETU after dermal exposure. The
ethod was also applied in an epidemiological study, showing that
282 samples could be analyzed with a good precision during a
hort time.
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